Business1 outlet
Roivant Expects FDA to Approve First Major Drug
Roivant's CEO Matt Gline anticipates FDA approval for the company's first major drug, which treats a debilitating skin disease. The drug is expected to launch and reach the market by September, marking a significant milestone for the pharmaceutical company.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
How does this lean?
Comments
0No comments yet. Say what you noticed in the coverage.
Trending